Stefan Hellbardt

Stefan Hellbardt, PhD, has over 15 years of experience in clinical development in the pharmaceutical industry. Stefan earned their PhD at the German Cancer Research Center and has held various roles, including Vice-President of Business Development and Scientific Affairs at Aptar Pharma since 2011. Prior to this, they were a Science Project Leader at Actelion from 2008 to 2011 and an International Group Leader in Clinical Development at ALTANA Pharma from 1999 to 2006. Stefan also held a similar role at Altana during the same time period.

Stefan Hellbardt received their PhD in Biology from The University of Freiburg, where they studied from 1985 to 1996.